DFB Pharma Wants S&N To Cough Up $26.7M In Dispute
A Texas-based private investment company has accused med-tech giant Smith & Nephew Inc. of wrongly withholding $26.7 million from a $782 million asset-purchase escrow account in a contract breach dispute now...To view the full article, register now.
Already a subscriber? Click here to view full article